Hepatosplenic T-cell lymphoma with hemophagocytic lymphohistiocytosis, revealed by fever of unknown origin

被引:0
作者
Kaoutar Meliani
Noufissa Alami Dribi
Widad Rhandour
Afaf Amarti Riffi
Zineb Khammar
Rhyzlane Berrady
机构
[1] CHU Hassan II,Department of Internal Medicine and Oncohematology
[2] CHU Hasssan II,Department of Anatomy and Pathology
来源
memo - Magazine of European Medical Oncology | 2023年 / 16卷
关键词
Cytogenetic karyotype; Fluorescence in situ hybridization; Molecular biology; Hepatosplenic T lymphoma gamma delta; Differential diagnosis;
D O I
暂无
中图分类号
学科分类号
摘要
The unusual peripheral lymphoma known as hepatosplenic T‑cell lymphoma (HSTCL) is a rare hematologic cancer. In this report, we discuss a case of HSTCL with hemophagocytic lymphohistiocytosis that was discovered due to a prolonged fever in a 27-year-old woman with no prior medical history. Infectious and autoimmune diseases were ruled out during the etiological review. Histopathological analysis of the bone marrow revealed hemophagocytosis. A diagnostic splenectomy was performed after the patient’s clinical condition worsened, showing no response to corticosteroids, and notable splenomegaly and hepatomegaly were observed on the positron emission tomography (PET) scan. The diagnosis of HSTCL was confirmed through pathological examination of the surgical specimens. In addition, a complementary genetic analysis revealed a gamma-delta T‑cell lymphoma. Hemophagocytic lymphohistiocytosis remains a diagnostic and therapeutic challenge, and physicians should always consider the possibility of an underlying hematologic disorder. Our case highlights the difficulties in diagnosing HSTCL due to the various possible causes of prolonged fever of unknown origin, as well as the nonspecific clinical presentation and the absence of peripheral lymphadenopathy. Our report discusses a new case of HSTCL associated with hemophagocytic lymphohistiocytosis to raise awareness among physicians about this rare entity. This association can be confusing and may lead to delays in diagnosis and thus worsening prognosis.
引用
收藏
页码:208 / 212
页数:4
相关论文
共 50 条
[11]  
Prindiville T(2018)Adult haemophagocytic syndrome Annu Rev Pathol Mech Dis 13 27-49
[12]  
Yabe M(2014)Macrophage activation syndrome in the era of biologic therapy Lancet 383 1503-1516
[13]  
Medeiros LJ(2016)Refractory macrophage activation syndrome in the setting of adult-onset Still disease with hemophagocytic lymphohistiocytosis detected on skin biopsy treated with canakinumab and tacrolimus Nat Rev Rheumatol 12 259-268
[14]  
Daneshbod Y(2019)Hepatosplenic T-cell lymphoma arising in patients with immunodysregularity disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review J Cutan Pathol 46 528-531
[15]  
Cho MW(2017)Hemophagocytic lymphohistiocytosis associated with hepatosplenic T-cell lymphoma: case report Ann Diagn Pathol 26 16-22
[16]  
Chin BB(2014)The genetic basis of hepatosplenic T cell lymphoma Autops Case Rep 4 19-24
[17]  
Kharfan-Dabaja MA(2017)T-cell lymphomas, version 2.2022, NCCN clinical practice guidelines in oncology Cancer Discov 7 369-379
[18]  
Kumar A(2022)undefined J Natl Compr Canc Netw 20 285-308
[19]  
Ayala E(undefined)undefined undefined undefined undefined-undefined
[20]  
Parikh SA(undefined)undefined undefined undefined undefined-undefined